Contralateral Portal Vein Embolization for Hepatectomy in the Setting of Hepatic Steatosis

Anderson, Christopher D.; Meranze, Steve; Bream Jr., Peter; Gorden, D. Lee; Wright, J. Kelly; Pinson, C. Wright; Chari, Ravi S.
July 2004
American Surgeon;Jul2004, Vol. 70 Issue 7, p609
Academic Journal
Portal vein embolization is evolving as an important adjunctive tool in hepatic surgery. In select patients, preoperative hypertrophy of the future remnant liver via contralateral portal vein embolization decreases postoperative liver dysfunction. Hepatic steatosis is the most common liver parenchymal disorder in Western populations. Moderate and severe degrees of hepatic steatosis convey an increased risk of postoperative liver dysfunction following major hepatic resections, but no studies exist examining the role of preoperative portal vein embolization in patients with hepatic steatosis. In this manuscript, we review the indications for portal vein embolization currently supported by the literature and present a patient with moderate to severe steatosis who successfully underwent portal vein embolization and a subsequent major liver resection.


Related Articles

  • Influence of Hepatic Parenchymal Histology on Outcome Following Right Hepatic Trisectionectomy. Neal, Christopher; Mann, Christopher; Pointen, Esme; McGregor, Angus; Garcea, Giuseppe; Metcalfe, Matthew; Berry, David; Dennison, Ashley // Journal of Gastrointestinal Surgery;Nov2012, Vol. 16 Issue 11, p2064 

    Background: Histological abnormalities in the non-tumour-bearing liver (NTBL) may influence outcome following hepatectomy. Effects will be most pertinent following right trisectionectomy but have yet to be specifically examined in this context. This study aimed to investigate the influence of...

  • Steatosis is a Lot More than Holes in Hepatocytes. Chakrabarti, Subrata // Saudi Journal of Gastroenterology;Jan2009, Vol. 15 Issue 1, p1 

    The article looks at the role of steatosis in chronic hepatitis C with reference to several studies. It cites that a study by A. Zubair et al published within the issue demonstrated the association between macrovesicular steatosis and fibrosis in liver disease. It adds that the study indicated...

  • Dideoxynucleoside Analogues Should Be Used Cautiously in Patients with Hepatic Steatosis. Zeremski, Marija; Talal, Andrew H. // Clinical Infectious Diseases;8/1/2006, Vol. 43 Issue 3, p373 

    The article reflects on the author's opinion on why dideoxynucleoside analogues should be used in patients with hepatic steatosis. The disease, defined as abnormal lipid accumulation in hepatocytes, is found in almost one third of the U.S. population. According to the author, patients with this...

  • The Role of Portal Vein Embolization Prior to Hepatic Resection for Primary and Secondary Hepatic Malignancies. Mckenzie, Shaun; Kim, Joseph // European Journal of Clinical & Medical Oncology;2010, Vol. 2 Issue 1, p1 

    Hepatic resection is the potential curative therapy for select hepatic malignancies, but inadequate future liver remnant (FLR) following resection may limit the performance of adequate surgical resection. As a result, portal vein embolization (PVE) has been developed to induce hypertrophy in the...

  • Morphologic Characterization of PhoenixBio (uPA+/+/SCID) Humanized Liver Chimeric Mouse Model. Peterson, Richard A.; Krull, David L.; Brown, H. Roger; de Serres, Mark // Drug Metabolism Letters;Aug2010, Vol. 4 Issue 3, p180 

    Morphological evaluation of humanized chimeric mouse livers from the PhoenixBio� (uPA+/+/SCID) mouse model show robust replacement and expansion with human hepatocytes, however areas of human hepatocytes had prominent steatosis and a variable lack of sinusoids which was consistent with...

  • Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. Giorgio, Valentina; Prono, Federica; Graziano, Francesca; Nobili, Valerio // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. NAFLD has emerged to be extremely prevalent, and predicted by obesity and male gender. It is defined by hepatic fat infiltration >5% hepatocytes, in the absence of other causes of liver pathology....

  • Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression. Jolly, Robert A.; Ciurlionis, Rita; Morfitt, David; Helgren, Mary; Patterson, Reid; Ulrich, Roger G.; Waring, Jeffrey F. // Toxicologic Pathology;Jul/Aug2004 Supplement 2, Vol. 32, p19 

    Hepatotoxicity characterized by microvesicular steatosis (MVS) is characterized by an abnormal accumulation of numerous small cytoplasmic lipid droplets in hepatocytes. Fulminant or progressive cases of microvesicular steatosis may lead to liver failure and death. Experimentally, short-chain...

  • Free fatly acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Maihi, Harmeet; Barreyro, Fernando J.; Isomoto, Hajume; Bronk, Steven F.; Gores, Gregory J. // Gut;Aug2007, Vol. 56 Issue 8, p1124 

    Background: Elevated circulating free fatty acids (FFA) contribute to the development of hepatic steatosis and promote hepatocyte apoptosis by incompletely defined mechanisms. Although the death ligand TRAIL has been implicated in a variety of pathological liver diseases, the role of TRAIL in...

  • Value of FibroScan in assessment of liver fibrosis in chronic hepatitis B patients with hepatocyte steatosis. LIU Kehui; XIE Jingdong; RUAN Jun // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 2, p153 

    To evaluate the value of FibroScan in assessing liver fibrosis in chronic hepatitis B (CHB) patients with hepatocyte steatosis. Methods Four hundred ad eighteen CHB patients who had undergone liver biopsy in Shanghai Ruiiin Hospital from January 2009 to December 2011 were enrolled in this study....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics